Johnson & Johnson (JNJ) is exploring a sale of its orthopedics business, DePuy Synthes, in a deal that could have a value of at least $20B.
Buyout firms have already expressed interest and the healthcare giant is apparently preparing documents in advance of potential negotiations, Bloomberg reported.
The news service noted that several big private equity houses are looking at working together to make an offer.
In its Q3 2025 earnings call in October, J&J management said it was looking to spin off the orthopedics unit.
